BioCardia, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.2M | $-7.9M | $-11.6M | $-11.9M | $-12.6M | $-15.0M | $-14.7M | $-14.0M |
| Depreciation & Amortization | $24.0K | $67.0K | $84.0K | $82.0K | $60.0K | $68.0K | $111.0K | $88.0K |
| Depreciation | $24.0K | $67.0K | $84.0K | $82.0K | $60.0K | $68.0K | $111.0K | $88.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $430.0K | $741.0K | $1.0M | $1.2M | $1.7M | $3.0M | $2.7M | $2.8M |
| Net Cash from Operating Activities | $-7.4M | $-7.9M | $-10.0M | $-10.6M | $-10.4M | $-12.4M | $-9.4M | $-11.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $7.0K | $6.0K | $12.0K | $70.0K | $116.0K | $32.0K | $146.0K | $66.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-7.0K | $-6.0K | $-12.0K | $-70.0K | $-116.0K | $-32.0K | $-146.0K | $-66.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $7.6M | $9.2M | $3.7M | $5.1M | $1.9M | $28.2M | $9.8M | $3.8M |
| Net Change in Cash | $125.0K | $1.3M | $-6.3M | $-5.5M | $-8.5M | $15.8M | $227.0K | — |
| Free Cash Flow | $-7.4M | $-7.9M | $-10.0M | $-10.6M | $-10.5M | $-12.4M | $-9.6M | $-11.1M |